TickerLeague

EBITDA for Solventum (SOLV)

According to Solventum's latest reported financial statements, the company's current EBITDA (TTM) is $2.81B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$2.81B

YoY change

+66.9%

5Y CAGR

+4.7%

Peak year (2025)

$2.55B

Cumulative EBITDA

$13.08B

EBITDA history chart for Solventum (SOLV) from 2020 to 2025

EBITDA history table for Solventum (SOLV) from 2020 to 2025

Fiscal yearPeriod endedReportedEBITDAYoY
2025$2.55B+66.9%
2024$1.53B-31.5%
2023$2.23B-1.9%
2022$2.27B-8.3%
2021$2.48B+22.0%
2020$2.03B

EBITDA values are taken from Solventum's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual EBITDA for Solventum (SOLV) came in at $2.55B – surged 66.9% year-over-year.

Solventum EBITDA has recorded the values shown across consecutive periods, with a +4.7% compound annual growth rate over 2020–2025 (5 years).

2025 marks the peak EBITDA at $2.55B, with the historical low of $1.53B recorded in 2024.

Solventum (SOLV) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.

Solventum EBITDA by Year

Solventum EBITDA 2025: $2.55B

Solventum EBITDA in 2025 was $2.55B, surged 66.9% from 2024. This figure represents the highest annual value in the available history.

Solventum EBITDA 2024: $1.53B

Solventum EBITDA in 2024 was $1.53B, plunged 31.5% below 2023. This figure represents the lowest annual value in the available history.

Solventum EBITDA 2023: $2.23B

Solventum EBITDA in 2023 was $2.23B, edged down 1.9% below 2022.

Solventum EBITDA 2022: $2.27B

Solventum EBITDA in 2022 was $2.27B, declined 8.3% below 2021.

Solventum EBITDA 2021: $2.48B

Solventum EBITDA in 2021 was $2.48B.

See more financial history for Solventum (SOLV).

Sector peers — EBITDA

Companies in the same sector as Solventum, ranked by their latest EBITDA.

CompanyEBITDASector
Novo Nordisk A/S (NVO)$156.73BHealthcare
Johnson & Johnson (JNJ)$41.05BHealthcare
Eli Lilly and Company (LLY)$27.94BHealthcare
Merck & Co., Inc. (MRK)$25.36BHealthcare
UnitedHealth Group Incorporated (UNH)$23.06BHealthcare
AstraZeneca PLC (AZN)$19.83BHealthcare
AbbVie Inc. (ABBV)$17.63BHealthcare
Amgen Inc. (AMGN)$15.84BHealthcare

Frequently asked questions

What is Solventum's EBITDA?

Latest reported EBITDA for Solventum (SOLV) is $2.81B (period ending December 31, 2025).

How has Solventum EBITDA changed year-over-year?

Solventum (SOLV) EBITDA changed +66.9% year-over-year on the latest annual filing.

What is the long-term growth rate of Solventum EBITDA?

Solventum (SOLV) EBITDA compound annual growth rate is +4.7% over the most recent 5 years available.

When did Solventum EBITDA hit its highest annual value?

Solventum EBITDA reached its highest annual value of $2.55B in 2025.

What was Solventum EBITDA in 2024?

Solventum (SOLV) EBITDA in 2024 was $1.53B.

What was Solventum EBITDA in 2025?

Solventum (SOLV) EBITDA in 2025 was $2.55B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.